Atea Pharmaceuticals, Inc.
Ticker: 1593899
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY2021 | Q3 FY2021 | Q2 FY2021 | Q2 FY2021 | Q1 FY2021 |
|---|---|---|---|---|---|
| INCOME | |||||
| Revenue | 32.81+0.0% | 32.81-45.7% | 60.39+0.0% | 60.39-8.5% | 65.99 |
| Total Income | 32.81+0.0% | 32.81-45.7% | 60.39+0.0% | 60.39-8.5% | 65.99 |
| EXPENSES | |||||
| Expenditure | 54.96+0.0% | 54.96+6.3% | 51.70+0.0% | 51.70+46.3% | 35.33 |
| Tax | 6.10+0.0% | 6.10-15.3% | 7.20+0.0% | 7.20 | — |
| PROFIT | |||||
| PBT | -22.09+0.0% | -22.09-352.7% | 8.74+0.0% | 8.74-71.5% | 30.71 |
| Net Profit | -28.19+0.0% | -28.19-1930.5% | 1.54+0.0% | 1.54-95.0% | 30.71 |
| KEY METRICS | |||||
| OPM % | -67.50% | -67.50%-81.88pp | 14.38% | 14.38%-32.07pp | 46.46% |
| NPM % | -85.93% | -85.93%-88.48pp | 2.55% | 2.55%-44.00pp | 46.55% |
| EPS | -0.34+0.0% | -0.34-1800.0% | 0.02+0.0% | 0.02-94.6% | 0.37 |
Corporate Events
Board MeetingAVIR
202618Jun
Board Meeting
Annual Meeting of Stockholders to elect Class III Directors,…
SEC Filing ↗